Spherix (SPEX) Sells Consulting Business, CEO Kruger Resigns, Company to Evaulate Alternatives
Tweet Send to a Friend
Spherix Incorporated (Nasdaq: SPEX) announced that, as an initial step in its restructuring program, it has sold all of the stock of Spherix Consulting, Inc. to ChromaDex, Inc (Nasdaq: CDXC).
Dr. Claire Kruger will continue to lead Spherix Consulting, the company she founded in 2008, as a division of ChromaDex. ChromaDex is an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic, and pharmaceutical industries.
Pending completion of its review of its strategic alternatives, Spherix Incorporated will continue to pursue development and commercialization of innovative drug, medical, and food technologies, including food and nutritional technologies and supplements. In connection with the disposition of Spherix Consulting, Dr. Kruger has resigned from the position of Chief Executive Officer and as a Director of Spherix. Dr. Robert A. Lodder, Jr. has assumed the additional position of Principal Executive Officer of the Company and Mr. Robert L. Clayton assumed the additional position of Corporate Secretary, both effective immediately. In light of the renewed focus on the Company's drug, medical and food development activities, Mr. Melissaratos, Mr. Peter, and Dr. Lodder, also resigned from the Board of Directors. Dr. Lodder will continue to serve as an officer.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Dr. Claire Kruger will continue to lead Spherix Consulting, the company she founded in 2008, as a division of ChromaDex. ChromaDex is an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic, and pharmaceutical industries.
Pending completion of its review of its strategic alternatives, Spherix Incorporated will continue to pursue development and commercialization of innovative drug, medical, and food technologies, including food and nutritional technologies and supplements. In connection with the disposition of Spherix Consulting, Dr. Kruger has resigned from the position of Chief Executive Officer and as a Director of Spherix. Dr. Robert A. Lodder, Jr. has assumed the additional position of Principal Executive Officer of the Company and Mr. Robert L. Clayton assumed the additional position of Corporate Secretary, both effective immediately. In light of the renewed focus on the Company's drug, medical and food development activities, Mr. Melissaratos, Mr. Peter, and Dr. Lodder, also resigned from the Board of Directors. Dr. Lodder will continue to serve as an officer.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Clearwire (CLWR) Approves Higher Sprint (S) Bid of $3.40/Share
- LRAD Corp, (LRAD), Iroquois Master Fund Enter Settlement
- Gentex (GNTX) CFO Dykman Resigns
Create E-mail Alert Related Categories
Corporate News, Management Changes, Mergers and Acquisitions
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
